Serum Brevican as a Biomarker of Cerebrovascular Disease in an Elderly Cognitively Impaired Cohort
Biomolecules · 07.01.2024 · 14 (1) · 75
DOI: 10.3390/biom14010075 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 07.01.2024. Verfasst von Rachel S L Chia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore. Hauptthemen laut MEDLINE: Alzheimer Disease, Brevican, Cerebrovascular Disorders, Dementia, Vascular. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Medical Research Council, NUS Healthy Longevity Translational Research Programme, Yong Loo Lin School of Medicine.
Abstract (Originalsprache)
In the brain, the extracellular matrix (ECM) composition shapes the neuronal microenvironment and can undergo substantial changes with cerebral pathology. Brevican is integral to the formation of the ECM’s neuroprotective perineuronal nets (PNNs). Decreased brevican levels were reported in vascular dementia (VaD) but not in Alzheimer’s disease (AD). However, the status of brevican in clinical cohorts with high concomitance of AD pathological burden and cerebrovascular disease (CeVD) is unclear. In this study, 32 non-cognitively impaired (NCI), 97 cognitively impaired no dementia (CIND), 46 AD, and 23 VaD participants recruited from memory clinics based in Singapore underwent neuropsychological and neuroimaging assessments, together with measurements of serum brevican. Association analyses were performed between serum brevican and neuroimaging measures of CeVDs, including white matter hyperintensities (WMHs), lacunes, cortical infarcts, and cerebral microbleeds. Using an aggregated score for CeVD burden, only CIND participants showed lower brevican levels with higher CeVD compared to those with lower CeVD burden (p = 0.006). Among the CeVD subtypes assessed, only elevated WMH burden was associated with lower brevican levels (OR = 2.7; 95% CI = 1.3–5.5). Our findings suggest that brevican deficits may play a role in early cerebrovascular damage in participants at risk of developing dementia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore.
- Memory Aging and Cognition Centre, National University Health System, Singapore 117600, Singapore.
- Future Health Technologies, Singapore-ETH Centre, Campus for Research Excellence and Technological Enterprise (CREATE), Singapore 138602, Singapore.
- Saw Swee Hock School of Public Health, National University of Singapore, Singapore 117597, Singapore.
- Departments of Epidemiology and Radiology & Nuclear Medicine, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands.
- Raffles Neuroscience Centre, Raffles Hospital, Singapore 188770, Singapore.
ORCID-Profile: Rachel S L Chia, Liu-Yun Wu, Kaung H T Salai, Narayanaswamy Venketasubramanian, Christopher P Chen, Mitchell K P Lai
Förderung
- National Medical Research Council
- NUS Healthy Longevity Translational Research Programme
- Yong Loo Lin School of Medicine
Zitieren
APA
Chia, R. S. L., Minta, K., Wu, L. Y., Salai, K. H. T., Chai, Y. L., Hilal, S., Venketasubramanian, N., Chen, C. P., Chong, J. R., & Lai, M. K. P. (2024). Serum Brevican as a Biomarker of Cerebrovascular Disease in an Elderly Cognitively Impaired Cohort. Biomolecules, 14(1), 75. https://doi.org/10.3390/biom14010075
Vancouver
Chia RSL, Minta K, Wu LY, Salai KHT, Chai YL, Hilal S, et al. Serum Brevican as a Biomarker of Cerebrovascular Disease in an Elderly Cognitively Impaired Cohort. Biomolecules. 2024;14(1):75. doi:10.3390/biom14010075
BibTeX
@article{Chia2024,
author = {Chia, Rachel S L and Minta, Karolina and Wu, Liu-Yun and Salai, Kaung H T and Chai, Yuek Ling and Hilal, Saima and Venketasubramanian, Narayanaswamy and Chen, Christopher P and Chong, Joyce R and Lai, Mitchell K P},
title = {Serum Brevican as a Biomarker of Cerebrovascular Disease in an Elderly Cognitively Impaired Cohort},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {1},
pages = {75},
doi = {10.3390/biom14010075}
}
EUVIMED